The Serum Institute of India, which makes the AstraZeneca COVID-19 vaccine, plans to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive said. Time.

“There will be an announcement in the next few days,” said Adar Poonawalla, quoted by the newspaper in an interview published Friday.

Mr Poonawalla said last week that the Serum Institute would be able to increase its monthly output to 100 million doses by July, later than the previous schedule of late May. Several states are running out of COVID-19 vaccines.

He hoped to increase the production capacity of the Serum Institute from 2.5 billion to 3 billion doses per year in six months, the Time reported, adding that he flew to London before Britain banned travelers from India eight days ago.

Coronavirus cases and deaths have increased in India. This surge led to a public health crisis and forced the government to seek oxygen, medicine and other essentials abroad.

Coronavirus cases in the country could peak between May 3 and 5, according to scientists informing the government.